Global Artificial Cardiac Valves Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028
“Global Artificial Cardiac Valves Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global artificial cardiac valves market report has been segmented on the basis of types of valve and region.
Global Artificial Cardiac Valves Market: Overview
Bio-prosthetic valves are used in heart valve replacement generally offer functional properties that are more similar to those of native valves such as hemodynamics, resistance to thrombosis. Implantation of prosthetic cardiac valves to treat hemodynamically significant aortic or mitral valve disease has become increasingly common. Artificial heart valves are composed primarily of metal or carbon alloys, and are classified according to their structure as caged-ball, single tilting-disk or bileaflet tilting-disk valves.
While designing artificial heart valves there is a need to look at fundamentals involving hemodynamics and blood shear stress as a result of interaction between the valve leaflets with the flow. CFD provides a platform to study and identify areas which cannot be captured experimentally compared to in vivo and in vitro experiments that are expensive and time consuming to setup.
Global Artificial Cardiac Valves Market: Dynamics
Increasing spending capacity, changing lifestyle pattern, and rising prevalence’s of cardiovascular diseases across the globe are some major factor expected to drive growth of the global market. In addition, well-developed healthcare infrastructure in developed countries, coupled with favorable reimbursement scenario is another factor expected to further boost growth of the global market to certain extent.
However, complications related to artificial heart value post surgeries such as thromboembolic and bleeding events, valve thrombosis, degeneration of bio-prostheses, para-valvar leak, and patient–prosthesis mismatch is a major factor resulting in lower adoption of artificial cardiac valve. This is expected to hamper growth of the global market. In addition, high cost of heart surgery and non-favorable policies are some other factors expected to challenge growth of the global market.
Increasing developing government expenditure on healthcare infrastructure, developing regulatory framework, and rising number of heart valve donors are factors expected to create potential revenue opportunities for player operating in the target market over the forecast period. In addition, increasing investment for technological advancements by major players is expected to further support growth of the target market to certain extent.
Global Artificial Cardiac Valves Market: Region
The market in North America is expected to dominate in the global market and is expected to continue its dominance over the forecast period. this can be attributed to well-developed healthcare infrastructure, favorable reimbursement policies, and presence of major players operating in countries in this region. In addition, increasing expansion activities through strategic mergers and acquisitions for technological advancements and increase customer base is expected to further support growth of the target market in this region.
The market in Asia Pacific is expected to witness faster growth, owing to developing regulatory scenario and presence of prominent players operating in emerging economies in this region. In addition, rising medical tourism in countries such as Malaysia, India, Singapore, etc., owing to developing healthcare infrastructure, coupled with low cost associated to cardiovascular surgeries is expected to further support growth of the target market in this region over the forecast period.
Global Artificial Cardiac Valves Market Segmentation
Segmentation by type of valve
- Biological heart valves
- Mechanical heart valves
- Transcatheter heart valves
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Boston Scientific Corporation
- Jude Medical, Inc.
- Colibri Heart Valve, Llc.
- Cryolife, Inc.
- Edwards Lifesciences Corporation
- Heart Leaflet Technology
- Jenavalve Technology, Inc.
- Livanova Plc
- Lepu Medical Technology Co Ltd.
- Medtronic Plc
- Micro Interventional Devices, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!